Healthcare Stocks in Focus: 12 Stocks Moving in Monday's Pre-Market Session

Several health care stocks are moving in Monday's pre-market session, with ENDRA Life Sciences and Aclarion leading the gains, up 45.8% and 34.34%, respectively. Forian and rYojbaba also rose, while Nanobiotix and Predictive Oncology increased by 15.84% and 15.55%, respectively. However, Tvardi Therapeutics declined by 88.0%, and other stocks like Catheter Precision, Aditxt, Quoin Pharmaceuticals, Bluejay Diagnostics, and Ensysce Biosciences fell by 15.95%, 15.92%, 12.69%, 12.23%, and 11.12%, respectively.

Several health care stocks have shown varied performance in Monday's pre-market session. ENDRA Life Sciences (NDRA) and Aclarion are leading the gains, with ENDRA up 45.8% and Aclarion up 34.34% respectively. Forian and rYojbaba also rose, while Nanobiotix and Predictive Oncology increased by 15.84% and 15.55% respectively. However, Tvardi Therapeutics declined by 88.0%, and other stocks like Catheter Precision, Aditxt, Quoin Pharmaceuticals, Bluejay Diagnostics, and Ensysce Biosciences fell by 15.95%, 15.92%, 12.69%, 12.23%, and 11.12% respectively.

ENDRA Life Sciences announced $4.9 million in funding commitments from institutional and cryptocurrency investors to launch a new digital asset treasury strategy, which could explain the significant increase in its stock price ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan^[2]. The company plans to focus on high-conviction decentralized finance holdings managed by Arca Investment Management LLC, and the deal is expected to close around October 14, 2025, pending customary conditions.

Health care stocks were generally lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and the Health Care Select Sector SPDR Fund (XLV) falling 1.5% Sector Update: Health Care Stocks Decline Late Afternoon^[1]. Novo Nordisk (NVO) shares were down 2.8% after winding down its cell therapy division that had been working on a potential cure for type 1 diabetes. Bristol-Myers Squibb (BMY) agreed to buy privately-held Orbital Therapeutics in an all-cash deal worth about $1.5 billion, boosting its cell therapy portfolio, but Bristol-Myers shares fell 1.6%. AstraZeneca (AZN) shares shed 1% after agreeing on a deal with President Donald Trump to lower drug prices in the US.

Financial stocks were advancing pre-bell Monday, with the Financial Select Sector SPDR Fund (XLF) 0.8% higher Sector Update: Financial Stocks Advance Pre-Bell Monday^[3]. JPMorgan Chase (JPM) shares were up more than 1% after announcing a new $1.5 trillion, 10-year plan to facilitate, finance, and invest in industries critical to US economic security. Banco Santander (SAN) shares were up more than 2% pre-bell after being selected by the US Treasury to purchase Argentine pesos in the market as part of a broader support effort.